NIH-funded research U01 cooperative agreement

Administrative supplement to extend IGVF work on variant interpretation

Official title: Administrative Supplement for IGVF Cost Extension

Funded at Northeastern University · NIH-11523090 · Data updated 2026-11-12

A one-year extension to finish and expand resources that help scientists interpret genetic variants and predict their effects on health.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionNortheastern University
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2021
Project endMay 31, 2027
Funding year2026
Award (this year)$564,812
NIH project number3U01HG012022-05S1
Project IDNIH-11523090 on NIH RePORTER

Who could benefit from this research

Could help

This grant is aimed at researchers and clinicians interpreting genetic variants in human diseases, not a specific patient population.

Less likely to help

Direct patient participation is not part of this grant; it focuses on methodological development and resources.

What this research studies

This grant extends ongoing work that has created calibration frameworks and new methods to interpret genetic variants. It includes expanding ExCALIBR to handle multiple data types, improving automated flagging of benign variants, and integrating diverse evidence to guide experiments. The goal is to finish key activities that support better understanding of how variants impact health and to share resources with the genomics community. The work is led by Northeastern University researchers and collaborators within the IGVF consortium.

Why it matters

Potential benefit: If successful, patients could benefit from faster, more accurate interpretation of genetic variants that influence disease risk and treatment decisions.

How similar studies have gone: Previous efforts have produced widely used calibration frameworks and prediction tools, with substantial adoption in the field.

Where this research is happening

  • Northeastern University
    Boston, United States
    Active

Researchers

  • Principal investigator: Radivojac, Predrag — Northeastern University
  • Study coordinator: Radivojac, Predrag

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.